Fluoguide AS (FLUO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Fluoguide AS (FLUO) has a cash flow conversion efficiency ratio of 4.485x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.97 Million ≈ $-1.18 Million USD) by net assets (Skr-2.44 Million ≈ $-263.12K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Fluoguide AS market capitalisation for the company's overall valuation and market capitalisation.
Fluoguide AS - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Fluoguide AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Fluoguide AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fluoguide AS ranked by their cash flow conversion efficiency. See Fluoguide AS (FLUO) debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Youngbo Chem
KO:014440
|
0.027x |
|
Seafire AB
ST:SEAF
|
0.002x |
|
Grodno S.A.
WAR:GRN
|
-0.005x |
|
Ersan Alisveris Hizmetleri & Gida Sanayi Ticaret AS
IS:KIMMR
|
0.093x |
|
Multi Retail Group Ltd
TA:MRG
|
0.584x |
|
Forum Markets, Incorporated
NASDAQ:FRMM
|
-0.121x |
|
Yonyu Plastics Co Ltd
TW:1323
|
0.013x |
|
WICE Logistics PCL
BK:WICE
|
0.006x |
Annual Cash Flow Conversion Efficiency for Fluoguide AS (2018–2024)
The table below shows the annual cash flow conversion efficiency of Fluoguide AS from 2018 to 2024. View FLUO stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr23.07 Million ≈ $2.48 Million |
Skr-29.15 Million ≈ $-3.14 Million |
-1.264x | +49.46% |
| 2023-12-31 | Skr12.72 Million ≈ $1.37 Million |
Skr-31.81 Million ≈ $-3.42 Million |
-2.501x | -112.36% |
| 2022-12-31 | Skr31.97 Million ≈ $3.44 Million |
Skr-37.65 Million ≈ $-4.05 Million |
-1.178x | -202.57% |
| 2021-12-31 | Skr38.70 Million ≈ $4.16 Million |
Skr-15.06 Million ≈ $-1.62 Million |
-0.389x | +80.60% |
| 2020-12-31 | Skr4.41 Million ≈ $474.69K |
Skr-8.85 Million ≈ $-952.08K |
-2.006x | +13.68% |
| 2019-12-31 | Skr4.54 Million ≈ $488.79K |
Skr-10.55 Million ≈ $-1.14 Million |
-2.323x | -1390.74% |
| 2018-12-31 | Skr7.00K ≈ $753.31 |
Skr-1.09K ≈ $-117.41 |
-0.156x | -- |
About Fluoguide AS
FluoGuide A/S, a clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. The company has a collaboration agreement with ZEISS Medical T… Read more